99 related articles for article (PubMed ID: 6084512)
1. Efficacy of human gamma-globulin preparation in experimental pseudomonas aeruginosa infections in mice and its mode of action.
Kamimura T
Arzneimittelforschung; 1984; 34(11):1528-34. PubMed ID: 6084512
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of immune gamma-globulin fraction on protection by antibiotic against corneal ulcers in experimental mice infected with Pseudomonas aeruginosa.
Kawaharajo K; Homma JY
Jpn J Exp Med; 1976 Jun; 46(3):155-65. PubMed ID: 822190
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
4. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Pseudomonas aeruginosa infection in mice.
Kawakita T; Yamada A; Mitsuyama M; Kumazawa Y; Nomoto K
Immunopharmacol Immunotoxicol; 1987; 9(4):523-40. PubMed ID: 3437105
[TBL] [Abstract][Full Text] [Related]
6. [Increase of resistance to Pseudomonas aeruginosa infection in mice caused by Staphylococcus aureus].
deRepentigny J; Mathieu LG; Coallier-Ascah J
Can J Microbiol; 1976 Jul; 22(7):1024-33. PubMed ID: 61060
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
8. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
9. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
Okada K; Kawaharajo K; Kasai T; Homma JY
Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
[TBL] [Abstract][Full Text] [Related]
10. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
Sokalska M; Maresz-Babczyszyn J
Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
[TBL] [Abstract][Full Text] [Related]
11. Effects of a glycopolypeptide from the slime of P. aeruginosa on phagocytosis by mouse macrophages.
Nadaud M
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):489-99. PubMed ID: 6426197
[TBL] [Abstract][Full Text] [Related]
12. Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.
Worgall S; Kikuchi T; Singh R; Martushova K; Lande L; Crystal RG
Infect Immun; 2001 Jul; 69(7):4521-7. PubMed ID: 11401995
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of S-sulfonated human gamma globulin against experimental infections in mice.
Tomioka H; Iwamura Y; Suzuki Y; Ohtomo S; Hashimoto Y
Infect Immun; 1980 Nov; 30(2):329-36. PubMed ID: 6160106
[TBL] [Abstract][Full Text] [Related]
15. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems.
Mizunaga S; Kamiyama T; Fukuda Y; Takahata M; Mitsuyama J
J Antimicrob Chemother; 2005 Jul; 56(1):91-6. PubMed ID: 15890721
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of siderophore, total matrix protease and elastase activity in Pseudomonas aeruginosa isolates from lower respiratory tract and extra-respiratory tract samples].
Demir M; Cevahir N; Kaleli I; Yildirim U; Sahin R; Cevik Tepeli E
Mikrobiyol Bul; 2008 Apr; 42(2):197-208. PubMed ID: 18697417
[TBL] [Abstract][Full Text] [Related]
17. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
[TBL] [Abstract][Full Text] [Related]
18. Interaction of elastase from Pseudomonas aeruginosa with polymorphonuclear leukocytes and serum.
Pajdak E; Pituch-Noworolska A; Stankiewicz D
Arch Immunol Ther Exp (Warsz); 1985; 33(4):499-505. PubMed ID: 3936453
[TBL] [Abstract][Full Text] [Related]
19. The role of OEP-antibodies in Pseudomonas aeruginosa infection.
Doi T; Nakajima T
Jpn J Exp Med; 1978 Aug; 48(4):287-95. PubMed ID: 101701
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]